相似文献
1
Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase.
Nat Protoc. 2009;4(9):1245-51. doi: 10.1038/nprot.2009.121. Epub 2009 Aug 6.
2
Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. I. Properties of NADPH-cytochrome P450 reductase and cytochrome P450 LM2 (2B4) monomers.
Arch Biochem Biophys. 1992 Nov 1;298(2):395-402. doi: 10.1016/0003-9861(92)90427-x.
3
One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
Biochem Pharmacol. 1992 Jan 22;43(2):343-52. doi: 10.1016/0006-2952(92)90297-v.
4
Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
Biochemistry. 1995 Jul 4;34(26):8380-9. doi: 10.1021/bi00026a020.
5
Quantitative analyses of electrostatic interactions between NADPH-cytochrome P450 reductase and cytochrome P450 enzymes.
J Biol Chem. 1994 Jun 3;269(22):15724-31.
6
Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
J Biol Chem. 1996 Nov 1;271(44):27438-44. doi: 10.1074/jbc.271.44.27438.
7
8
Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. II. Kinetic parameters of reductase and monooxygenase reactions.
Arch Biochem Biophys. 1992 Nov 1;298(2):403-12. doi: 10.1016/0003-9861(92)90428-y.
9
Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
J Biochem Mol Toxicol. 2002;16(6):286-97. doi: 10.1002/jbt.10054.
10
Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.
Drug Metab Dispos. 2011 Jun;39(6):944-6. doi: 10.1124/dmd.111.039321. Epub 2011 Mar 23.
引用本文的文献
1
The ROS-FOXO pathway mediates broad-spectrum detoxification of acaricides in Tetranychus cinnabarinus.
Commun Biol. 2025 Aug 23;8(1):1274. doi: 10.1038/s42003-025-08726-0.
2
Characterisation of the thermophilic P450 CYP116B305 identified using metagenomics-derived sequence data from an Australian hot spring.
Appl Microbiol Biotechnol. 2025 May 31;109(1):133. doi: 10.1007/s00253-025-13521-2.
3
Optimization of CYP27A1 recombinant protein expression.
Protein Expr Purif. 2025 Sep;233:106748. doi: 10.1016/j.pep.2025.106748. Epub 2025 May 26.
4
Evolutionary insights into the selectivity of sterol oxidising cytochrome P450 enzymes based on ancestral sequence reconstruction.
Chem Sci. 2025 May 13. doi: 10.1039/d5sc01863c.
5
Decoding the selective chemical modulation of CYP3A4.
Nat Commun. 2025 Apr 10;16(1):3423. doi: 10.1038/s41467-025-58749-8.
6
Characterisation of the Self-Sufficient Cytochrome P450 CYP116B234 From Rhodococcus globerulus and Its Suggested Native Role in 2-Hydroxyphenylacetic Acid Metabolism.
Microb Biotechnol. 2025 Mar;18(3):e70125. doi: 10.1111/1751-7915.70125.
7
Use of Whole Cells and Cell-Free Extracts of Catalase-Deficient E. coli for Peroxygenase-Catalyzed Reactions.
Biotechnol Bioeng. 2025 Jun;122(6):1376-1385. doi: 10.1002/bit.28959. Epub 2025 Feb 25.
8
Standard Protocols for Characterising Primary and In Vitro-Generated Human Hepatocytes.
J Cell Mol Med. 2025 Feb;29(3):e70390. doi: 10.1111/jcmm.70390.
9
Liver fatty acid binding protein FABP1 transfers substrates to cytochrome P450 4A11 for catalysis.
J Biol Chem. 2025 Feb;301(2):108168. doi: 10.1016/j.jbc.2025.108168. Epub 2025 Jan 8.
10
The Molecular Basis of the Intrinsic and Acquired Resistance to Azole Antifungals in .
J Fungi (Basel). 2024 Nov 26;10(12):820. doi: 10.3390/jof10120820.
本文引用的文献
1
High-throughput fluorescence assay of cytochrome P450 3A4.
Nat Protoc. 2009;4(9):1258-61. doi: 10.1038/nprot.2009.123. Epub 2009 Aug 6.
2
Chromatographic assays of drug oxidation by human cytochrome P450 3A4.
Nat Protoc. 2009;4(9):1252-7. doi: 10.1038/nprot.2009.122. Epub 2009 Aug 6.
3
Structural basis for androgen specificity and oestrogen synthesis in human aromatase.
Nature. 2009 Jan 8;457(7226):219-23. doi: 10.1038/nature07614.
4
Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide.
FEBS J. 2008 Jul;275(14):3706-17. doi: 10.1111/j.1742-4658.2008.06518.x.
5
Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
Arch Biochem Biophys. 2007 Aug 15;464(2):176-86. doi: 10.1016/j.abb.2007.04.033. Epub 2007 May 15.
6
Predicting in vivo drug interactions from in vitro drug discovery data.
Nat Rev Drug Discov. 2005 Oct;4(10):825-33. doi: 10.1038/nrd1851.
7
Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase.
Arch Biochem Biophys. 2005 Aug 15;440(2):204-11. doi: 10.1016/j.abb.2005.06.019.
8
Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.
Drug Metab Dispos. 2004 Nov;32(11):1201-8. doi: 10.1124/dmd.104.000794. Epub 2004 Aug 10.
9
Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies.
J Biol Chem. 1962 Aug;237:2652-60.
10
A new cytochrome in liver microsomes.
J Biol Chem. 1962 Apr;237:1375-6.
Zotero 插件